• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Kronos Bio Inc (NQ: KRON )

    0.8500 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Kronos Bio Inc

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Cancer Player Kronos Bio To Stop Lanraplenib Combo Therapy Blood Cancer Study
    Kronos Bio Inc (NASDAQ: KRON) says that after the review of data from the phase 1b portion of its phase 1b/2 trial of lanraplenib in combination with gilteritinib in FLT3-mutated relapsed/refractory... 
    Via Benzinga
    Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Kronos Bio: Q1 Earnings Insights
    Via Benzinga
    Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates... 
    Via Benzinga
    Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
    Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio To Present Interim Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at AACR-NCI-EORTC and Host Virtual Investor Event on October 13
    Management to host conference call and webcast on October 13 at 4:30 PM ET with key opinion leader and KB-0742 trial investigator, Miguel Villalona-Calero, M.D., of City of Hope 
    From Kronos Bio, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Kronos Bio Announces Departure of Chief Financial Officer and Head of Corporate Development
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Reports Recent Business Progress and Second-Quarter 2023 Financial Results
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Names Marc Besman, Ph.D., as Senior Vice President of Regulatory Affairs and Clinical Quality Assurance
    Dr. Besman brings more than 25 years of regulatory affairs and drug development experience and a track record of successfully advancing clinical programs 
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Participation in Upcoming Investor Conferences
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Reports Recent Business Progress and First-Quarter 2023 Financial Results
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Appoints Roger Dansey, M.D., to Board of Directors
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Changes to Board of Directors
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Thursday
      During Thursday's session, 99 companies made new 52-week lows. 
    Via Benzinga
    Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results
    From Kronos Bio, Inc.
    Via GlobeNewswire
    Kronos Bio Announces Participation in 43rd Annual Cowen Health Care Conference
    From Kronos Bio, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.